Monday, 3 January 2022
Theranos jury hears audio recordings from Elizabeth Holmes
Bob Sutton
work_matters
Guilty or innocent, @JohnCarreyrou and testimony at Elizabeth Holmes' trial shows the virtues of bureaucrats and bureaucracy. Holmes was angry at lowly administrators who asked her tough questions and refused to break rules for Theranos. #frictionproject cdn.smehost.net/threeuncannyfourcom-neonhummediaprod/wp-content/uploads/2021/11/BAD-BLOOD-EP-9-MILITARY.pdf
Twitter
Christopher Worsham, MD
ChrisWorsham
"Experts say 'fraud is complicated'" in the #ElizabethHolmes #Theranos trial. Is it, though, in this case? Guilty or not, the verdict of this trial is lose-lose for patients' trust in health care & government. Here's why (THREAD🧵) : www.npr.org/2021/12/29/1068639311/elizabeth-holmes-jury-theranos-fraud-case?utm_campaign=storyshare&utm_source=twitter.com&utm_medium=social
Twitter
Stephanie Sierra
StephanieABC7
DAY 6: Jury continues deliberating in #ElizabethHolmes criminal fraud trial. The 8 men + 4 women will decide whether to convict the former #Theranos CEO of 11 counts of fraud and conspiracy. #abc7now pic.twitter.com/c8u1cAWlty
Twitter
Alexis Keenan
alexiskweed
Convening for DAY #6, the jury in USA v. #ElizabethHolmes has resumed deliberations #Theranos
Twitter
Sunday, 26 December 2021
Oxford AstraZeneca Covid-19 vaccine ‘preventing lagged rise in deaths
Clive Dix said the durable cellular immunity response produced by the AZ jab can potentially ‘last for life’.
PA Reporter
The use of the Oxford AstraZeneca Covid-19 vaccine in vulnerable people may be resulting in a lower death toll in the UK compared to Europe according to the former chief of the country’s vaccine taskforce.
Clive Dix said the durable cellular immunity response produced by the AZ jab can potentially “last for life”.
The Oxford/AstraZeneca jab was approved last December, and vaccines were initially rolled out among the older and the most vulnerable in society.
Mr Dix told The Daily Telegraph: “If you look across Europe, with the rise in cases, there’s also a corresponding lagged rise in deaths, but not in the UK, and we have to understand that.” Mr Dix told The Daily Telegraph: “If you look across Europe, with the rise in cases, there’s also a corresponding lagged rise in deaths, but not in the UK, and we have to understand that.”He added: “I personally believe that’s because most of our vulnerable people were given the AstraZeneca vaccine.”
Clive Dix said the durable cellular immunity response produced by the AZ jab can potentially “last for life”.
The Oxford/AstraZeneca jab was approved last December, and vaccines were initially rolled out among the older and the most vulnerable in society.
Mr Dix told The Daily Telegraph: “If you look across Europe, with the rise in cases, there’s also a corresponding lagged rise in deaths, but not in the UK, and we have to understand that.” Mr Dix told The Daily Telegraph: “If you look across Europe, with the rise in cases, there’s also a corresponding lagged rise in deaths, but not in the UK, and we have to understand that.”He added: “I personally believe that’s because most of our vulnerable people were given the AstraZeneca vaccine.”
Mr Dix told the newspaper: “We’ve seen early data that the Oxford jab produces a very durable cellular response and if you’ve got a durable cellular immunity response then they can last for a long time.
“It can last for life in some cases.”
AstraZeneca has faced both praise and criticism during the pandemic, with its Covid jab hailed as being one of the first on the market and for its low cost in comparison to other jabs.
The rollout of the Oxford/AstraZeneca jab in the UK saw Government advisers recommending under-40s should be offered alternatives due to evidence it may be linked to very rare blood clots.
Fears over links to blood clots also saw some European countries pause their use of the jab.
https://www.independent.co.uk/news/uk/astrazeneca-oxford-europe-fears-b1982611.html
Labels:
AstraZeneca,
COVID-19,
Improve immunity,
Vaccines
Subscribe to:
Posts (Atom)



